UNC0642 treatment caused a viability defect even in the context of a leukemia-stroma interaction (Fig. 2F, G), consistent with the observation that G9a inhibitors force T-ALL to undergo apoptosis (Supplementary Fig. 2H). Here, EHMT2 is linked to acute lymphoblastic leukemia.